LY6K and urinary bladder carcinoma: LY6K: Increased expression of LY6K has also been reported in metastatic ER positive breast cancer (41–43), esophageal squamous cancer (44), gingivobuccal cancers (45), bladder cancer (46), and lung cancer (47).